Bataille C, Bercoff E, Pariente E A, Valla D, Lebrec D
Gastroenterology. 1984 Jan;86(1):129-33.
Systemic and splanchnic hemodynamics, renal blood flow, and renal function were studied in 13 patients with cirrhosis both before and 1 h after oral administration of 40 mg of propranolol (acute administration) and 1 mo after continuous administration of this substance at doses reducing the heart rate by 25% (chronic administration). Cardiac output and the gradient between wedged and free hepatic venous pressures significantly decreased after acute and chronic administration of propranolol; mean arterial pressure did not change significantly and systemic vascular resistance significantly increased. Renal blood flow and renal vascular resistance did not change significantly after acute administration of propranolol and renal function did not change significantly after acute or chronic administration of propranolol. We conclude that propranolol does not alter renal function in patients with cirrhosis who are in good physical condition.
对13例肝硬化患者在口服40mg普萘洛尔前、口服后1小时(急性给药)以及连续给药1个月(慢性给药,剂量为使心率降低25%)后,分别研究了全身和内脏血流动力学、肾血流量及肾功能。急性和慢性给予普萘洛尔后,心输出量以及肝静脉楔压与游离压之间的梯度显著降低;平均动脉压无显著变化,全身血管阻力显著增加。急性给予普萘洛尔后,肾血流量和肾血管阻力无显著变化,急性或慢性给予普萘洛尔后,肾功能无显著变化。我们得出结论,普萘洛尔不会改变身体状况良好的肝硬化患者的肾功能。